M. De Jong‐Bakker

1.3k total citations
18 papers, 1.0k citations indexed

About

M. De Jong‐Bakker is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, M. De Jong‐Bakker has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in M. De Jong‐Bakker's work include Estrogen and related hormone effects (5 papers), Cancer Risks and Factors (4 papers) and Bone health and treatments (3 papers). M. De Jong‐Bakker is often cited by papers focused on Estrogen and related hormone effects (5 papers), Cancer Risks and Factors (4 papers) and Bone health and treatments (3 papers). M. De Jong‐Bakker collaborates with scholars based in Netherlands, United Kingdom and Belgium. M. De Jong‐Bakker's co-authors include W J Nooijen, Johannes M.G. Bonfrèr, P.A.H. van Noord, Augustinus A. M. Hart, Peter F. Bruning, P.F. Bruning, F. J. Cleton, A.A.M. Hart, J. M. G. Bonfrer and A. van den Ende and has published in prestigious journals such as The Lancet, Annals of the New York Academy of Sciences and British Journal of Cancer.

In The Last Decade

M. De Jong‐Bakker

18 papers receiving 966 citations

Peers

M. De Jong‐Bakker

ONCOL

GENET

EDM

L. Demers United States

J.‐E. Damber Sweden

Riikka Huovinen Finland

K.-D. Schulz Germany

S.-O. Andersson Sweden

Mahesh Parmar United Kingdom

K. Gary Barnette United States

Kyung Hee Yi South Korea

Patricia K. Landis United States

Glenn Tisman United States

L. Demers United States

M. De Jong‐Bakker

504 ×0.9

ONCOL

283 ×0.8

208 ×0.8

GENET

162 ×0.7

EDM

132 ×0.6

Citations per year, relative to M. De Jong‐Bakker M. De Jong‐Bakker (= 1×) peers L. Demers

Countries citing papers authored by M. De Jong‐Bakker

Since Specialization

Citations

This map shows the geographic impact of M. De Jong‐Bakker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. De Jong‐Bakker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. De Jong‐Bakker more than expected).

Fields of papers citing papers by M. De Jong‐Bakker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. De Jong‐Bakker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. De Jong‐Bakker. The network helps show where M. De Jong‐Bakker may publish in the future.

Co-authorship network of co-authors of M. De Jong‐Bakker

This figure shows the co-authorship network connecting the top 25 collaborators of M. De Jong‐Bakker. A scholar is included among the top collaborators of M. De Jong‐Bakker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. De Jong‐Bakker. M. De Jong‐Bakker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Bruning, Peter F., Johannes M.G. Bonfrèr, P.A.H. van Noord, et al.. (1992). Insulin resistance and breast‐cancer risk. International Journal of Cancer. 52(4). 511–516. 288 indexed citations

Bruning, P.F., Johannes M.G. Bonfrèr, A.A.M. Hart, et al.. (1992). Body measurements, estrogen availability and the risk of human breast cancer: A case‐control study. International Journal of Cancer. 51(1). 14–19. 100 indexed citations

Jong‐Bakker, M. De, et al.. (1990). Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer. British Journal of Cancer. 61(2). 308–310. 144 indexed citations

Bruning, P.F., et al.. (1990). 90058640 Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer. Maturitas. 12(4). 357–357. 7 indexed citations

Bruning, P.F., J. M. G. Bonfrer, A. A. M. Hart, et al.. (1989). Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer. European Journal of Cancer and Clinical Oncology. 25(2). 369–376. 16 indexed citations

Hart, A.A.M., et al.. (1988). Tamoxifen, serum lipoproteins and cardiovascular risk. British Journal of Cancer. 58(4). 497–499. 120 indexed citations

Bruning, P.F., Johannes M.G. Bonfrèr, Anca C. Ansink, N.S. Russell, & M. De Jong‐Bakker. (1988). Why is breast cancer so frequent in The Netherlands?. PubMed. 14(2). 115–22. 8 indexed citations

Hilkens, John, J. M. G. Bonfrer, V. Kroezen, et al.. (1987). Comparison of circulating mam‐6 and cea levels and correlation with the estrogen receptor in patients with breast cancer. International Journal of Cancer. 39(4). 431–435. 16 indexed citations

Bruning, P.F., Johannes M.G. Bonfrèr, L. G. Bobrow, et al.. (1986). Plasma Hormones in Premenopausal Women with Benign Breast Disease. Annals of the New York Academy of Sciences. 464(1). 579–581. 4 indexed citations

10.

Hilkens, John, V. Kroezen, J. M. G. Bonfrer, M. De Jong‐Bakker, & P.F. Bruning. (1986). MAM-6 antigen, a new serum marker for breast cancer monitoring.. PubMed. 46(5). 2582–7. 110 indexed citations

11.

Jong‐Bakker, M. De, et al.. (1985). Primary hypothyroidism in breast cancer patients with irradiated supraclavicular lymph nodes. British Journal of Cancer. 51(5). 659–663. 41 indexed citations

12.

Engelsman, E, et al.. (1984). Pros and cons of aminoglutethimide for advanced postmenopausal breast cancer. Breast Cancer Research and Treatment. 4(4). 289–295. 16 indexed citations

13.

Bruning, P.F., J. M. G. Bonfrer, M. De Jong‐Bakker, & W.J. Nooyen. (1984). Influence of acth on aminoglutethimide induced reduction of plasma steroids in postmenopausal breast cancer. Journal of Steroid Biochemistry. 21(3). 293–298. 11 indexed citations

14.

Bruning, P.F., A.A.M. Hart, M. De Jong‐Bakker, et al.. (1983). 41 Parity and age influence hormonal risk factors of breast cancer. Journal of Steroid Biochemistry. 19. 14–14. 8 indexed citations

15.

Jong‐Bakker, M. De, Augustinus A. M. Hart, J.-P. Persijn, & F. J. Cleton. (1981). Prognostic significance of CEA in breast cancer: a statistical study. European Journal of Cancer and Clinical Oncology. 17(12). 1307–1313. 25 indexed citations

16.

Kwa, H. G., F. J. Cleton, M. De Jong‐Bakker, et al.. (1976). Plasma prolactin and its relationship to risk factors in human breast cancer. International Journal of Cancer. 17(4). 441–447. 32 indexed citations

17.

Jong‐Bakker, M. De, F. J. Cleton, J. D’Amaro, J.J. Keuning, & J. J. van Rood. (1974). HL-A antigens and breast cancer. European Journal of Cancer (1965). 10(9). 555–558. 9 indexed citations

18.

Kwa, H. G., E Engelsman, M. De Jong‐Bakker, & F. J. Cleton. (1974). PLASMA-PROLACTIN IN HUMAN BREAST CANCER. The Lancet. 303(7855). 433–435. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact